E Fund Management Co., Ltd. Intercept Pharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.99 - $18.71 $64,325 - $120,473	-6,439 Reduced 29.05%	15,728 $292,000
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $67,647 - $142,302	7,377 Added 49.88%	22,167 $245,000
Q1 2023 May 11, 2023	BUY	$12.53 - $21.71 $10,750 - $18,627	858 Added 6.16%	14,790 $199,000
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $18,297 - $25,389	-1,576 Reduced 10.16%	13,932 $172,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $25,042 - $40,404	-2,051 Reduced 11.68%	15,508 $216,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $68,817 - $120,047	6,128 Added 53.61%	17,559 $242,000
Q1 2022 May 12, 2022	BUY	$13.37 - $17.79 $64,603 - $85,961	4,832 Added 73.22%	11,431 $186,000
Q1 2021 May 12, 2021	BUY	$19.33 - $37.75 $127,558 - $249,112	6,599 New	6,599 $152,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.